trending Market Intelligence /marketintelligence/en/news-insights/trending/wblm1d9n0cylotka-rwl_q2 content esgSubNav
In This List

Revance appoints CFO

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Revance appoints CFO

Revance Therapeutics Inc. said it appointed Tobin Schilke as the company's CFO, effective Nov. 5.

Schilke has been serving as the CFO of Achaogen Inc. since 2016.

Prior to Achaogen, Schilke spent 13 years at Roche Holding AG and its subsidiary Genentech Inc. in a variety of senior finance and operational roles.

Newark, Calif.-based Revance Therapeutics is developing a generic version of Allergan PLC's Botox.